Horizon Discovery
Eleni Santoukou is a Senior Scientist at Horizon Discovery since February 2020, bringing extensive experience in cancer research and therapeutics. Prior to this role, Eleni served as a Scientist at Cancer Research UK from September 2016 to February 2020. Eleni began a research career as a PhD student at The Institute of Cancer Research, where involvement in the Drug Target Discovery Lab within the Cancer Therapeutics Unit took place from March 2012 to February 2016.
This person is not in any offices
Horizon Discovery
2 followers
Horizon builds human disease models and reagents derived from genetically-engineered cells that its customers use, or that are deployed on their behalf to: gain knowledge of the genetic drivers of disease; develop novel drugs or cell therapies targeted.